Firivumab

Biorbyt

Firivumab

10

Research Use Only

Monoclonal

Unconjugated

98.00%

Firivumab (CT-P22; CT120), a human IgG1 monoclonal antibody targeting influenza A virus hemagglutinin (Anti-IAV HA), demonstrates neutralization capabilities against multiple strains including H1N1, H5N1, H6N1, H6N2, H8N4, H8N8, H9N2, and H12N7. It has also shown to protect mice from the H1N1 virus [1] [2] [3].

-20°C,2°C to 8°C

12352203